-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Kodi B (02487.HK) announced that the Group's CU-20101 (injectable type A botulinum toxin) biological product marketing license application (BLA) has been accepted by the China Drug Administration. The indication is to improve moderate to severe brow lines.

Zhitongcaijing·09/02/2026 22:33:09
Listen to the news
Zhitong Finance App News, Kodi B (02487.HK) announced that the Group's CU-20101 (injectable type A botulinum toxin) biological product marketing license application (BLA) has been accepted by the China Drug Administration. The indication is to improve moderate to severe brow lines.